Interesting facts
Interesting Facts about Ethyl 8-Fluoro-5-Methyl-6-Oxo-4H-Imidazo[1,5-a][1,4]Benzodiazepine-3-Carboxylate
Ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate is a fascinating member of the benzodiazepine class of compounds, known for their diverse pharmacological properties. Here are some engaging insights about this unique compound:
- Multi-functional Nature: This compound exhibits a complex structure which allows for potential interactions with multiple biological targets, making it of interest for drug discovery and development.
- Fluorine as a Game Changer: The incorporation of a fluorine atom often enhances the lipophilicity of the molecule, potentially improving its bioavailability and efficacy in therapeutic applications.
- Medicinal Chemistry: Compounds within this class are widely researched for their anxiolytic, sedative, and anticonvulsant properties, showcasing their importance in treating various psychiatric and neurological disorders.
- Imidazole Ring: The imidazole core is known for its presence in several biologically active compounds, and in this particular structure, it further contributes to its unique pharmacological profile.
- Research Potential: Investigating such compounds can lead to the discovery of new therapeutic agents with improved safety and effectiveness profiles.
In summary, ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate stands as a promising candidate in the chemical and pharmaceutical fields. Its intricate design not only reflects the sophisticated nature of medicinal chemistry but also sparks interest for future research endeavors.
Synonyms
flumazenil
78755-81-4
Anexate
Flumazepil
Romazicon
Lanexat
Mazicon
Ro 15-1788
fumazenil
Flumazenilum
Flumazenilo
Flumazenilum [Latin]
Flumazenil (Ro 15-1788)
Flumazenilo [Spanish]
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate
Ro-15-1788
C15H14FN3O3
Flumazil
[11C]flumazenil
ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
Ro 151788
Ro15-1788
NSC-759193
BRN 4763661
CHEBI:5103
DTXSID2023064
UNII-40P7XK9392
RO-151788
Ro 15-1788/000
MFCD00242764
CHEMBL407
40P7XK9392
RO-1722
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
MLS000028850
Ro-151788000
DTXCID703064
4H-Imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester
ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate
RO-41-8157
Ro-15-1788/000
Flumazenil [USAN:USP:INN:BAN]
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5-methyl-5,6-dihydro-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate
Flumazenilum (Latin)
NSC 759193
NCGC00015439-06
SMR000058450
FLUMAZENIL (MART.)
FLUMAZENIL [MART.]
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
FLUMAZENIL (USP-RS)
FLUMAZENIL [USP-RS]
FLUMAZENIL (EP MONOGRAPH)
FLUMAZENIL [EP MONOGRAPH]
FLUMAZENIL (USP MONOGRAPH)
FLUMAZENIL [USP MONOGRAPH]
Flumazenil (USAN:USP:INN:BAN)
[3H]Ro15-1788
CAS-78755-81-4
SR-01000075879
Flumenazil
Roma
[11C]flumazenil (PET ligand)
Romazicon (TN)
ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate
FYP
Flumazenil (Standard)
Tocris-1328
FLUMAZENIL [MI]
FLUMAZENIL [INN]
FLUMAZENIL [JAN]
Opera_ID_1516
FLUMAZENIL [USAN]
Lopac-F-6300
FLUMAZENIL [VANDF]
Biomol-NT_000285
UPCMLD-DP137
FLUMAZENIL [WHO-DD]
Lopac0_000506
SCHEMBL79030
Flumazenil (JAN/USP/INN)
MLS000759529
MLS001076354
MLS001424108
BIDD:GT0766
Flumazenil, 1mg/ml in Ethanol
BPBio1_001190
Flumazenil - Bio-X trade mark
GTPL4192
GTPL4367
FLUMAZENIL [ORANGE BOOK]
UPCMLD-DP137:001
BDBM26263
HY-B0009R
V03AB25
HMS2051D17
HMS2089B15
HMS2234F06
HMS3261F13
HMS3267P09
HMS3374E10
HMS3393D17
HMS3412G20
HMS3657K11
HMS3676G20
HMS3884G11
Pharmakon1600-01505701
BCP07573
HY-B0009
Flumazenil, >99% (HPLC), solid
Tox21_110148
Tox21_500506
HB0915
NSC759193
PDSP1_001778
PDSP2_001761
s1332
AKOS015888159
Tox21_110148_1
AC-6846
CCG-100968
CS-0629
DB01205
FF23326
LP00506
NC00218
SDCCGSBI-0050490.P003
NCGC00015439-01
NCGC00015439-02
NCGC00015439-03
NCGC00015439-04
NCGC00015439-05
NCGC00015439-07
NCGC00015439-08
NCGC00015439-09
NCGC00015439-11
NCGC00015439-14
NCGC00015439-22
NCGC00025116-01
NCGC00025116-02
NCGC00025116-03
NCGC00025116-04
NCGC00025116-05
NCGC00261191-01
AS-13923
BF164469
SBI-0050490.P002
DB-056331
EU-0100506
F0958
NS00010398
SW197598-2
C07825
D00697
EN300-123018
F 6300
AB00572626-12
AB00572626-13
AB00572626_14
AB00572626_15
A839484
Q421920
SR-01000075879-1
SR-01000075879-3
SR-01000075879-7
BRD-K98769987-001-01-3
BRD-K98769987-001-12-0
BRD-K98769987-001-21-1
BRD-K98769987-001-22-9
BRD-K98769987-001-23-7
Z1546610479
Flumazenil, United States Pharmacopeia (USP) Reference Standard
4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 8- fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester
8-Fluoro-5,6-dihydro-5-methyl-6-oxo -4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, ethyl ester
8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester
8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester
ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0,2,6]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate
ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaene-5-carboxylate
ethyl 8-fluoranyl-5-methyl-6-oxidanylidene-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylate
ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-3-carboxylate
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate #
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate;Anexate
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate;Anexate;8-Fluoro-5,6-dihydro-5-methyl-6 -oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester
Solubility of Ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
The solubility of ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate (C18H13FN3O3) can be affected by several factors, given its complex structure. Understanding solubility is crucial for applications in pharmaceuticals, as it influences bioavailability and drug formulation. Here are some key aspects:
In summary, while ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate's solubility exhibits notable variable behavior in different solvents, predicting its behavior requires considering both chemical structure and environmental conditions. As with many pharmaceutical compounds, thorough solubility studies are essential.